PROCEPT BioRobotics Corporation PRCT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 17.47% | 22.69% | 29.26% | 37.22% | 50.07% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.47% | 22.69% | 29.26% | 37.22% | 50.07% |
| Cost of Revenue | 19.84% | 25.53% | 24.89% | 27.95% | 24.85% |
| Gross Profit | 16.17% | 21.11% | 31.87% | 43.13% | 68.80% |
| SG&A Expenses | 21.36% | 24.47% | 27.64% | 33.48% | 37.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.69% | 23.93% | 24.75% | 28.28% | 28.12% |
| Operating Income | -31.11% | -27.64% | -13.10% | -7.50% | 13.09% |
| Income Before Tax | -36.37% | -30.82% | -13.67% | -4.63% | 15.96% |
| Income Tax Expenses | -62.73% | -39.82% | -1.25% | -14.95% | -- |
| Earnings from Continuing Operations | -35.80% | -30.44% | -13.61% | -4.55% | 15.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.80% | -30.44% | -13.61% | -4.55% | 15.47% |
| EBIT | -31.11% | -27.64% | -13.10% | -7.50% | 13.09% |
| EBITDA | -31.19% | -28.12% | -12.65% | -6.66% | 14.77% |
| EPS Basic | -31.70% | -25.05% | -7.60% | 2.21% | 21.23% |
| Normalized Basic EPS | -35.57% | -28.70% | -7.65% | 2.12% | 21.67% |
| EPS Diluted | -31.70% | -25.05% | -7.60% | 2.21% | 21.23% |
| Normalized Diluted EPS | -35.57% | -28.70% | -7.65% | 2.12% | 21.67% |
| Average Basic Shares Outstanding | 3.20% | 4.24% | 5.35% | 6.56% | 7.16% |
| Average Diluted Shares Outstanding | 3.20% | 4.24% | 5.35% | 6.56% | 7.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |